Literature DB >> 6465711

Mycobacterium gordonae in the acquired immunodeficiency syndrome.

J Chan, J C McKitrick, R S Klein.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6465711     DOI： 10.7326/0003-4819-101-3-400_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

2.  Evaluation of the LiPA MYCOBACTERIA assay for identification of mycobacterial species from BACTEC 12B bottles.

Authors:  N Miller; S Infante; T Cleary
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

3.  Prospective study of mycobacterial infections in patients with cystic fibrosis.

Authors:  L Hjelte; B Petrini; G Källenius; B Strandvik
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

4.  Mycobacterium gordonae pseudoinfection associated with a contaminated antimicrobial solution.

Authors:  J I Tokars; M M McNeil; O C Tablan; K Chapin-Robertson; J E Patterson; S C Edberg; W R Jarvis
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.

Authors:  B A Brown; R J Wallace; G O Onyi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

6.  Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.

Authors:  Clare L van Halsema; Violet N Chihota; Nicolaas C Gey van Pittius; Katherine L Fielding; James J Lewis; Paul D van Helden; Gavin J Churchyard; Alison D Grant
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.